Pattern of plasma cyclic nucleotides and related hormones in liver cirrhosis and hepatocellular carcinoma

Fabrizia Bamonti-Catena, Maddalena Peracchi, Dario Conte, Luigi Cantalamessa, Elettra Lorenzano, Alessandra Orsatti, Francesco Salerno

Research output: Contribution to journalArticle

Abstract

To evaluate the pattern of plasma cyclic adenosine 3',5'-monophosphate, cyclic guanosine 3',5'-monophosphate, atrial natriuretic factor and glucagon levels in different stages of chronic liver diseases, we measured these variables in 20 normal subjects, 25 patients with genetic hemochromatosis, associated with liver cirrhosis in 19 cases and not in six, eight patients with compensated and 15 with decompensated alcoholic or posthepatitic cirrhosis, and 12 with hepatocellular carcinoma. All variables were within the normal range in non-cirrhotic hemochromatotic patients. Cyclic adenosine 3',5'-monophosphate levels were within the normal range (9.5-15.7 nmol/l) in hemochromatotic cirrhotics and elevated in other patients. Cyclic guanosine 3',5'-monophosphate, atrial natriuretic factor and glucagon were above the normal ranges (1.92-5.91 nmol/l, 8.8-62.7 ng/l, and 39-165 ng/l, respectively) in most patients with cirrhosis both with and without hemochromatosis and in most individuals with hepatocellular carcinoma. Cyclic guanosine 3',5'-monophosphate correlated with atrial natriuretic factor in the former groups but not in the latter. These findings indicate that glucagon and atrial natriuretic factor hypersecretion is an early event in cirrhosis, regardless of its etiology. In hepatocellular carcinoma, the underlying cirrhosis may account for most hormonal and metabolic changes although cyclic guanosine 3',5'-monophosphate increases could also be due to the neoplastic process per se.

Original languageEnglish
Pages (from-to)709-714
Number of pages6
JournalClinical Chemistry and Laboratory Medicine
Volume36
Issue number9
DOIs
Publication statusPublished - 1998

Fingerprint

Cyclic Nucleotides
Cyclic GMP
Atrial Natriuretic Factor
Liver Cirrhosis
Liver
Hepatocellular Carcinoma
Glucagon
Hormones
Plasmas
Fibrosis
Reference Values
Hemochromatosis
Cyclic AMP
Neoplastic Processes
Liver Diseases
Chronic Disease

Keywords

  • Atrial natriuretic factor
  • Cirrhosis
  • Cyclic nucleotides
  • Genetic hemochromatosis
  • Glucagon
  • Hepatocellular carcinoma

ASJC Scopus subject areas

  • Clinical Biochemistry

Cite this

Bamonti-Catena, F., Peracchi, M., Conte, D., Cantalamessa, L., Lorenzano, E., Orsatti, A., & Salerno, F. (1998). Pattern of plasma cyclic nucleotides and related hormones in liver cirrhosis and hepatocellular carcinoma. Clinical Chemistry and Laboratory Medicine, 36(9), 709-714. https://doi.org/10.1515/CCLM.1998.125

Pattern of plasma cyclic nucleotides and related hormones in liver cirrhosis and hepatocellular carcinoma. / Bamonti-Catena, Fabrizia; Peracchi, Maddalena; Conte, Dario; Cantalamessa, Luigi; Lorenzano, Elettra; Orsatti, Alessandra; Salerno, Francesco.

In: Clinical Chemistry and Laboratory Medicine, Vol. 36, No. 9, 1998, p. 709-714.

Research output: Contribution to journalArticle

Bamonti-Catena, F, Peracchi, M, Conte, D, Cantalamessa, L, Lorenzano, E, Orsatti, A & Salerno, F 1998, 'Pattern of plasma cyclic nucleotides and related hormones in liver cirrhosis and hepatocellular carcinoma', Clinical Chemistry and Laboratory Medicine, vol. 36, no. 9, pp. 709-714. https://doi.org/10.1515/CCLM.1998.125
Bamonti-Catena, Fabrizia ; Peracchi, Maddalena ; Conte, Dario ; Cantalamessa, Luigi ; Lorenzano, Elettra ; Orsatti, Alessandra ; Salerno, Francesco. / Pattern of plasma cyclic nucleotides and related hormones in liver cirrhosis and hepatocellular carcinoma. In: Clinical Chemistry and Laboratory Medicine. 1998 ; Vol. 36, No. 9. pp. 709-714.
@article{1dc753b8c3414b4fbc65049f71dd71c0,
title = "Pattern of plasma cyclic nucleotides and related hormones in liver cirrhosis and hepatocellular carcinoma",
abstract = "To evaluate the pattern of plasma cyclic adenosine 3',5'-monophosphate, cyclic guanosine 3',5'-monophosphate, atrial natriuretic factor and glucagon levels in different stages of chronic liver diseases, we measured these variables in 20 normal subjects, 25 patients with genetic hemochromatosis, associated with liver cirrhosis in 19 cases and not in six, eight patients with compensated and 15 with decompensated alcoholic or posthepatitic cirrhosis, and 12 with hepatocellular carcinoma. All variables were within the normal range in non-cirrhotic hemochromatotic patients. Cyclic adenosine 3',5'-monophosphate levels were within the normal range (9.5-15.7 nmol/l) in hemochromatotic cirrhotics and elevated in other patients. Cyclic guanosine 3',5'-monophosphate, atrial natriuretic factor and glucagon were above the normal ranges (1.92-5.91 nmol/l, 8.8-62.7 ng/l, and 39-165 ng/l, respectively) in most patients with cirrhosis both with and without hemochromatosis and in most individuals with hepatocellular carcinoma. Cyclic guanosine 3',5'-monophosphate correlated with atrial natriuretic factor in the former groups but not in the latter. These findings indicate that glucagon and atrial natriuretic factor hypersecretion is an early event in cirrhosis, regardless of its etiology. In hepatocellular carcinoma, the underlying cirrhosis may account for most hormonal and metabolic changes although cyclic guanosine 3',5'-monophosphate increases could also be due to the neoplastic process per se.",
keywords = "Atrial natriuretic factor, Cirrhosis, Cyclic nucleotides, Genetic hemochromatosis, Glucagon, Hepatocellular carcinoma",
author = "Fabrizia Bamonti-Catena and Maddalena Peracchi and Dario Conte and Luigi Cantalamessa and Elettra Lorenzano and Alessandra Orsatti and Francesco Salerno",
year = "1998",
doi = "10.1515/CCLM.1998.125",
language = "English",
volume = "36",
pages = "709--714",
journal = "Clinical Chemistry and Laboratory Medicine",
issn = "1434-6621",
publisher = "Walter de Gruyter GmbH",
number = "9",

}

TY - JOUR

T1 - Pattern of plasma cyclic nucleotides and related hormones in liver cirrhosis and hepatocellular carcinoma

AU - Bamonti-Catena, Fabrizia

AU - Peracchi, Maddalena

AU - Conte, Dario

AU - Cantalamessa, Luigi

AU - Lorenzano, Elettra

AU - Orsatti, Alessandra

AU - Salerno, Francesco

PY - 1998

Y1 - 1998

N2 - To evaluate the pattern of plasma cyclic adenosine 3',5'-monophosphate, cyclic guanosine 3',5'-monophosphate, atrial natriuretic factor and glucagon levels in different stages of chronic liver diseases, we measured these variables in 20 normal subjects, 25 patients with genetic hemochromatosis, associated with liver cirrhosis in 19 cases and not in six, eight patients with compensated and 15 with decompensated alcoholic or posthepatitic cirrhosis, and 12 with hepatocellular carcinoma. All variables were within the normal range in non-cirrhotic hemochromatotic patients. Cyclic adenosine 3',5'-monophosphate levels were within the normal range (9.5-15.7 nmol/l) in hemochromatotic cirrhotics and elevated in other patients. Cyclic guanosine 3',5'-monophosphate, atrial natriuretic factor and glucagon were above the normal ranges (1.92-5.91 nmol/l, 8.8-62.7 ng/l, and 39-165 ng/l, respectively) in most patients with cirrhosis both with and without hemochromatosis and in most individuals with hepatocellular carcinoma. Cyclic guanosine 3',5'-monophosphate correlated with atrial natriuretic factor in the former groups but not in the latter. These findings indicate that glucagon and atrial natriuretic factor hypersecretion is an early event in cirrhosis, regardless of its etiology. In hepatocellular carcinoma, the underlying cirrhosis may account for most hormonal and metabolic changes although cyclic guanosine 3',5'-monophosphate increases could also be due to the neoplastic process per se.

AB - To evaluate the pattern of plasma cyclic adenosine 3',5'-monophosphate, cyclic guanosine 3',5'-monophosphate, atrial natriuretic factor and glucagon levels in different stages of chronic liver diseases, we measured these variables in 20 normal subjects, 25 patients with genetic hemochromatosis, associated with liver cirrhosis in 19 cases and not in six, eight patients with compensated and 15 with decompensated alcoholic or posthepatitic cirrhosis, and 12 with hepatocellular carcinoma. All variables were within the normal range in non-cirrhotic hemochromatotic patients. Cyclic adenosine 3',5'-monophosphate levels were within the normal range (9.5-15.7 nmol/l) in hemochromatotic cirrhotics and elevated in other patients. Cyclic guanosine 3',5'-monophosphate, atrial natriuretic factor and glucagon were above the normal ranges (1.92-5.91 nmol/l, 8.8-62.7 ng/l, and 39-165 ng/l, respectively) in most patients with cirrhosis both with and without hemochromatosis and in most individuals with hepatocellular carcinoma. Cyclic guanosine 3',5'-monophosphate correlated with atrial natriuretic factor in the former groups but not in the latter. These findings indicate that glucagon and atrial natriuretic factor hypersecretion is an early event in cirrhosis, regardless of its etiology. In hepatocellular carcinoma, the underlying cirrhosis may account for most hormonal and metabolic changes although cyclic guanosine 3',5'-monophosphate increases could also be due to the neoplastic process per se.

KW - Atrial natriuretic factor

KW - Cirrhosis

KW - Cyclic nucleotides

KW - Genetic hemochromatosis

KW - Glucagon

KW - Hepatocellular carcinoma

UR - http://www.scopus.com/inward/record.url?scp=0031695572&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031695572&partnerID=8YFLogxK

U2 - 10.1515/CCLM.1998.125

DO - 10.1515/CCLM.1998.125

M3 - Article

C2 - 9804395

AN - SCOPUS:0031695572

VL - 36

SP - 709

EP - 714

JO - Clinical Chemistry and Laboratory Medicine

JF - Clinical Chemistry and Laboratory Medicine

SN - 1434-6621

IS - 9

ER -